Valitor (Biotechnology) Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
Valitor (Biotechnology) General Information
Description
Developer of a multivalent biopolymer technology platform designed to create advanced ophthalmic medicines with extended therapeutic durability and improved safety. The company's technology offers an interchangeable polymer architecture that enhances potency, stability, and tissue retention, enabling biopharmaceutical developers in ophthalmology and related fields to deliver long-lasting treatments that significantly improve patient outcomes.
Contact Information
Website
www.valitorbio.comCorporate Office
- 2956 San Pablo Avenue
- Berkeley, CA 94702
- United States
Corporate Office
- 2956 San Pablo Avenue
- Berkeley, CA 94702
- United States
Valitor (Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Later Stage VC | 05-May-2026 | Completed | Pre-Clinical Trials | |||
| 10. Secondary Transaction - Private | 03-Oct-2023 | Completed | Pre-Clinical Trials | |||
| 9. Accelerator/Incubator | 20-Sep-2023 | Completed | Pre-Clinical Trials | |||
| 8. Later Stage VC (Series B) | 05-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 7. Grant | 01-Jul-2021 | Completed | Pre-Clinical Trials | |||
| 6. Seed Round | 21-Sep-2018 | Completed | Pre-Clinical Trials | |||
| 5. Grant | 01-Jan-2018 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Feb-2018 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 28-Oct-2015 | $50K | $50K | Completed | Pre-Clinical Trials | |
| 2. Grant | 01-May-2014 | $2.12M | Completed | Pre-Clinical Trials |
Valitor (Biotechnology) Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Valitor (Biotechnology) Comparisons
Industry
Financing
Details
Valitor (Biotechnology) Competitors (2)
One of Valitor (Biotechnology)’s 2 competitors is Inhibrx, a Formerly VC-backed company based in La Jolla, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inhibrx | Formerly VC-backed | La Jolla, CA | ||||
| Monte Rosa Therapeutics | Formerly VC-backed | Boston, MA |
Valitor (Biotechnology) Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Valitor (Biotechnology) Patents
Valitor (Biotechnology) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026112108-A1 | Multivalent protein conjugates | Pending | 20-Nov-2024 | ||
| EP-4794689-A1 | Multivalent aptamer-polymer conjugates | Pending | 18-Oct-2023 | ||
| WO-2025085621-A1 | Multivalent aptamer-polymer conjugates | Inactive | 18-Oct-2023 | ||
| AU-2023254257-A1 | Humanized multivalent protein conjugates | Pending | 15-Apr-2022 | ||
| EP-4508078-A2 | Humanized multivalent protein conjugates | Pending | 15-Apr-2022 | C07K16/22 |
Valitor (Biotechnology) Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Valitor (Biotechnology) Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| California Life Sciences | Accelerator/Incubator | |||
| 5Y Capital | Venture Capital | Minority | ||
| Angel Physicians Fund | Angel Group | Minority | ||
| ExSight Ventures | Venture Capital | Minority | ||
| First Spark Ventures | Venture Capital | Minority |
Valitor (Biotechnology) FAQs
-
When was Valitor (Biotechnology) founded?
Valitor (Biotechnology) was founded in 2010.
-
Where is Valitor (Biotechnology) headquartered?
Valitor (Biotechnology) is headquartered in Berkeley, CA.
-
What is the size of Valitor (Biotechnology)?
Valitor (Biotechnology) has 15 total employees.
-
What industry is Valitor (Biotechnology) in?
Valitor (Biotechnology)’s primary industry is Biotechnology.
-
Is Valitor (Biotechnology) a private or public company?
Valitor (Biotechnology) is a Private company.
-
What is Valitor (Biotechnology)’s current revenue?
The current revenue for Valitor (Biotechnology) is .
-
How much funding has Valitor (Biotechnology) raised over time?
Valitor (Biotechnology) has raised $30.6M.
-
Who are Valitor (Biotechnology)’s investors?
California Life Sciences, 5Y Capital, Angel Physicians Fund, ExSight Ventures, and First Spark Ventures are 5 of 11 investors who have invested in Valitor (Biotechnology).
-
Who are Valitor (Biotechnology)’s competitors?
Inhibrx and Monte Rosa Therapeutics are competitors of Valitor (Biotechnology).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
